WO2013025073A3 - 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 - Google Patents
유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 Download PDFInfo
- Publication number
- WO2013025073A3 WO2013025073A3 PCT/KR2012/006541 KR2012006541W WO2013025073A3 WO 2013025073 A3 WO2013025073 A3 WO 2013025073A3 KR 2012006541 W KR2012006541 W KR 2012006541W WO 2013025073 A3 WO2013025073 A3 WO 2013025073A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preventing
- treating diabetes
- extract
- composition
- diabetes complications
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물에 관한 것으로, 더욱 자세하게는 유홍초 추출물을 함유하는 당뇨병 합병증 예방 또는 치료용 약학조성물 및 건강기능식품에 관한 것이다. 본 발명에 따른 조성물은 혈당 강하 및 뇨단백 저해 작용을 나타내어, 당뇨합병증의 예방 또는 치료에 탁월한 효과를 가진다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0081857 | 2011-08-17 | ||
KR20110081857 | 2011-08-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013025073A2 WO2013025073A2 (ko) | 2013-02-21 |
WO2013025073A3 true WO2013025073A3 (ko) | 2013-05-30 |
Family
ID=47715611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/006541 WO2013025073A2 (ko) | 2011-08-17 | 2012-08-17 | 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20130020623A (ko) |
WO (1) | WO2013025073A2 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961626A (zh) * | 2014-03-28 | 2014-08-06 | 南阳医学高等专科学校 | 治疗眼底出血的中草药丸 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101550390B1 (ko) * | 2011-08-18 | 2015-09-08 | 한국생명공학연구원 | 유홍초속에서 분리한 신규화합물 및 이를 유효성분으로 포함하는 당뇨병의 예방 또는 치료용 조성물 |
CN104623406B (zh) * | 2014-12-11 | 2018-01-16 | 苏风军 | 治疗虹膜睫状体炎的中药方剂 |
CN104906514A (zh) * | 2015-06-23 | 2015-09-16 | 包晓娜 | 一种治疗眩晕的中药组合物 |
KR101938991B1 (ko) | 2017-09-25 | 2019-01-15 | 강원대학교산학협력단 | 당뇨병성 합병증의 예방 또는 치료용 약제학적 조성물 |
US11020405B2 (en) | 2017-09-25 | 2021-06-01 | Kangwon National University University-Industry Cooperation Foundation | Method for prevention or treatment of diabetic complications |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110095835A (ko) * | 2010-02-19 | 2011-08-25 | 한국생명공학연구원 | 둥근잎유홍초 추출물을 함유하는 당뇨병 치료용 약학적 조성물 |
-
2012
- 2012-08-17 WO PCT/KR2012/006541 patent/WO2013025073A2/ko active Application Filing
- 2012-08-17 KR KR1020120089992A patent/KR20130020623A/ko not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110095835A (ko) * | 2010-02-19 | 2011-08-25 | 한국생명공학연구원 | 둥근잎유홍초 추출물을 함유하는 당뇨병 치료용 약학적 조성물 |
Non-Patent Citations (3)
Title |
---|
MASATERU, ONO ET AL.: "Two New Glycosidic Acids, Quamoclinic Acids G and H of the Resin Glycosides (Convolvulin) from the Seeds of Quamoclit pennata", CHEM. PHARM. BULLETIN, vol. 58, no. 9, June 2010 (2010-06-01), pages 1232 - 1235 * |
NAOKI ASANO ET AL.: "dihydroxynortropane alkaloids from calystegine-producing plants", PHYTOCHEMISTRY, vol. 57, no. ISSUE, July 2001 (2001-07-01), pages 721 - 726 * |
RAJENDRAN, K. ET AL.: "Pharmacognostical Identification of Stem and Root of Ipomoea quamoclit(Linn.)", NATURAL PRODUCT SCIENCES, vol. 13, no. 4, 2007, pages 273 - 278 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961626A (zh) * | 2014-03-28 | 2014-08-06 | 南阳医学高等专科学校 | 治疗眼底出血的中草药丸 |
CN103961626B (zh) * | 2014-03-28 | 2017-06-20 | 南阳医学高等专科学校 | 治疗眼底出血的中草药丸 |
Also Published As
Publication number | Publication date |
---|---|
WO2013025073A2 (ko) | 2013-02-21 |
KR20130020623A (ko) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1214168A1 (zh) | 通過控制血糖水平用於治療糖尿病及相關疾病的組合物、方法以及用途 | |
WO2011090270A3 (ko) | 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물 | |
WO2013025073A3 (ko) | 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물 | |
WO2009055331A3 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
WO2012108689A3 (ko) | 피부미백, 항산화 및 ppar 활성을 갖는 신규 화합물 및 이의 의학적 용도 | |
WO2009153496A3 (fr) | Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies | |
WO2012033378A3 (ko) | 비만억제 활성과 혈당강하 효능이 있는 꾸지뽕 및 의이인을 포함하는 조성물 및 이의 용도 | |
PH12015502263A1 (en) | Composition for preventing or treating hangover | |
WO2013022740A3 (en) | Gpr35 ligands and the uses thereof | |
WO2012108677A3 (ko) | 피부미백, 항산화 및 ppar 활성을 갖는 신규 화합물 및 이의 의학적 용도 | |
WO2012012278A3 (en) | Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex | |
EP2510933A4 (en) | COMPOSITION FOR ENHANCING BLOOD CIRCULATION CONTAINING AN EXTRACT OF LINDERA OBTUSILOBA FORMING ACTIVE INGREDIENT | |
WO2011095882A8 (en) | Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency | |
WO2010094837A3 (en) | Sugar product | |
WO2012134169A3 (ko) | 조각인 추출물을 포함하는 폐암 치료용 조성물 및 건강 기능성 식품 | |
WO2016190566A3 (ko) | 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품 | |
WO2011102690A3 (ko) | 둥근잎유홍초 추출물을 함유하는 당뇨병 치료용 약학적 조성물 | |
WO2011014520A3 (en) | Compounds and compositions as modulators of gpr119 activity | |
WO2011118957A3 (ko) | 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물 | |
WO2014026013A3 (en) | Methods for maintaining or improving health, well-being and/or a physiological function in a subject | |
WO2012105816A3 (ko) | 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물 | |
WO2013000895A9 (en) | Dha and epa in the reduction of oxidative stress | |
WO2010104281A3 (ko) | 아토피성 피부질환 개선용 조성물 | |
WO2015042495A3 (en) | Metformin salts to treat type2 diabetes | |
WO2011156820A9 (en) | Compositions, methods and uses for treatment of type 1 diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12823810 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12823810 Country of ref document: EP Kind code of ref document: A2 |